Total Payments
$1,003
2023 Payments
$145.54
Companies
9
Transactions
30
Medicare Patients
665
Medicare Billing
$148,721
Payment Breakdown by Category
Food & Beverage$1,003 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,003 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $310.37 | 10 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $232.36 | 4 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $194.14 | 6 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $121.60 | 1 | $0 (2021) |
| Alkermes, Inc. | $51.55 | 3 | $0 (2023) |
| Indivior Inc. | $33.47 | 2 | $0 (2023) |
| ITI, Inc. | $30.40 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $15.87 | 1 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $12.80 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $145.54 | 7 | ABBVIE INC. ($56.48) |
| 2022 | $474.94 | 17 | Teva Pharmaceuticals USA, Inc. ($180.74) |
| 2021 | $382.08 | 6 | AbbVie Inc. ($151.68) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CNS | ||||||
| 08/02/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: BH | ||||||
| 05/10/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: CNS | ||||||
| 04/12/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Central Nervous System | ||||||
| 03/15/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neuroscience | ||||||
| 02/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Central Nervous System | ||||||
| 11/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Central Nervous System | ||||||
| 09/19/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Central Nervous System | ||||||
| 09/06/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Central Nervous System | ||||||
| 08/17/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: CNS | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: PSYCHIATRY | ||||||
| 06/08/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: BH | ||||||
| 05/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 04/20/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: PSYCHIATRY | ||||||
| 04/14/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $106.02 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 347 | $47,638 | $18,621 |
| 2022 | 3 | 213 | 1,044 | $142,663 | $53,138 |
| 2021 | 5 | 278 | 1,056 | $143,203 | $55,364 |
| 2020 | 3 | 90 | 419 | $54,929 | $21,598 |
Total Patients
665
Total Services
2,866
Medicare Billing
$148,721
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 294 | $36,162 | $15,026 | 41.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 18 | 18 | $5,940 | $2,043 | 34.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $2,584 | $788.85 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 18 | $2,952 | $763.20 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 101 | 927 | $114,021 | $43,443 | 38.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 57 | 61 | $20,130 | $7,125 | 35.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 55 | 56 | $8,512 | $2,570 | 30.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 114 | 881 | $108,363 | $42,834 | 39.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 76 | 80 | $12,160 | $3,884 | 31.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 38 | 38 | $9,310 | $3,499 | 37.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 23 | 23 | $7,590 | $2,772 | 36.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 34 | $5,780 | $2,374 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 52 | 379 | $46,617 | $18,566 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 24 | $5,880 | $2,244 | 38.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 16 | 16 | $2,432 | $787.52 | 32.4% |
About Megan Ledbetter, NP-C
Megan Ledbetter, NP-C is a Family healthcare provider based in Geneva, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2018. The National Provider Identifier (NPI) number assigned to this provider is 1669964078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Megan Ledbetter, NP-C has received a total of $1,003 in payments from pharmaceutical and medical device companies, with $145.54 received in 2023. These payments were reported across 30 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,003).
As a Medicare-enrolled provider, Ledbetter has provided services to 665 Medicare beneficiaries, totaling 2,866 services with total Medicare billing of $148,721. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Geneva, OH
- Active Since 05/31/2018
- Last Updated 05/31/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1669964078
Products in Payments
- VRAYLAR (Drug) $310.37
- REXULTI (Drug) $220.22
- AUSTEDO (Drug) $194.14
- NUEDEXTA (Drug) $121.60
- PERSERIS (Drug) $33.47
- CAPLYTA (Drug) $30.40
- Vivitrol (Drug) $22.07
- LYBALVI (Drug) $17.02
- INVEGA SUSTENNA (Drug) $15.87
- NUPLAZID (Drug) $12.80
- ARISTADA (Drug) $12.46
- ABILIFY MAINTENA (Drug) $12.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Geneva
Terri Haskins, Np (Family Nurse Pra, NP (FAMILY NURSE PRA
Family — Payments: $5,522
Family $5,522
Mrs. Staci Hooker, Fnp-C, FNP-C
Family — Payments: $3,981
Family $3,981
Dr. Rachel Miller, Dnp, Fnp-Bc, DNP, FNP-BC
Family — Payments: $3,034
Family $3,034
Ashley Carey
Family — Payments: $1,652
Family $1,652
Sarah Disanto, N.p, N.P
Family — Payments: $1,003
Family $1,003
Melissa Sherman, Fnp-C, FNP-C
Family — Payments: $889.55
Family $889.55